BioElectronics Corporation Issues Shareholder Letter Discussing New Initiatives

FREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (Pink Sheets:BIEL), the maker of ActiPatch™, the drug free anti-inflammatory patch, with an embedded battery operated microchip delivering continuous pulse therapy that revolutionizes the way people heal, today issued the following letter to shareholders from CEO, Andrew Whelan.
MORE ON THIS TOPIC